دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Acknowledgement of Reviewers 2022
doi : 10.1016/S0167-8140(22)04585-6
Volume 177, December 2022, Page viii
A giant in radiotherapy has gone: Herman D. Suit 1926–2022
Jens Overgaard Michael Baumann
doi : 10.1016/j.radonc.2022.11.020
Volume 177, December 2022, Pages A1-A2
Ideal regimen for induction chemotherapy in nasopharyngeal cancer: Still a hot issue?
Francesca De Felice a,⇑, Alessio Cirillo b , Andrea Botticelli
doi : 10.1016/j.radonc.2022.10.033
Volume 177, December 2022, Pages 111-112
Not only volumes matter for breast radiation therapy
Orit Kaidar-Person a,b,c , Oreste Gentilini d , Philip Poortmans
doi : 10.1016/j.radonc.2022.10.021
Volume 177, December 2022, Pages 236-237
Breast cancer radiotherapy: Is it time to rethink the indication?
Birgitte Vrou Offersen, Marie Overgaard, Jens Overgaard
doi : 10.1016/j.radonc.2022.10.009
Volume 177, December 2022, Pages 238-239
Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations
Chirayu G. Patel a,⇑, Jennifer Peterson b , Marianne Aznar c , Yolanda D. Tseng d , Scott Lester b , Deanna Pafundi e , Stella Flampouri f , Pranshu Mohindra g , Rahul R. Parikh h , Raymond Mailhot Vega i , Laila Konig j , John P. Plastaras k , James E. Bates f , Pierre Loap l , Youlia M. Kirova l , Ester Orlandi m , Carola Lütgendorf-Caucig n , Georgios Ntentas o,p , Bradford Hoppe
doi : 10.1016/j.radonc.2022.10.003
Volume 177, December 2022, Pages 21-32
Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy
BhanuPrasad Venkatesulu a,b,1,⇑, Prashanth Giridhar c,1 , Lincoln Pujari c , Brian Chou a,b , Jae Han Lee a , Alec M. Block a,b , Rituraj Upadhyay d , James S. Welsh a,b , Matthew M. Harkenrider a , Sunil Krishnan e , Vivek Verma f , Cheng En Hsieh g,h , Satyajit Pradhan c , William Small Jr a , Abhishek A. Solanki
doi : 10.1016/j.radonc.2022.10.019
Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC)
Anna Merlotti a,⇑, Daniela Alterio b , Ester Orlandi c , Séverine Racadot d , Pierluigi Bonomo e , Pierfrancesco Franco f , Elisa D’Angelo g , Stefano Ursino h , Yoann Pointreau i , Michel Lapeyre j , Pierre Graff k , Alessia Di Rito l , Angela Argenone m , Daniela Musio n , Francesca De Felice o , Francesco Dionisi p , Giuseppe Fanetti q , Ida D’Onofrio r , Liliana Belgioia s , Marta Maddalo t , Melissa Scricciolo u , Jean Bourhis v , Elvio Russi a , Juliette Thariat
doi : 10.1016/j.radonc.2022.10.035
Volume 177, December 2022, Pages 95-104
Evidence on the efficacy of postoperative radiotherapy (PORT) in low-intermediate risk squamous cell carcinoma of the oral cavity (OSCC) remains inconclusive.
Diagnostic accuracy of MRI techniques for treatment response evaluation in patients with brain metastasis: A systematic review and meta-analysis
Wouter H.T. Teunissen a,b,h , Chris W. Govaerts d , Miranda C.A. Kramer g , Jeremy A. Labrecque c , Marion Smits a,b,h , Linda Dirven e,f , Anouk van der Hoorn
doi : 10.1016/j.radonc.2022.10.026
Volume 177, December 2022, Pages 121-133
Treatment response assessment in patients with brain metastasis uses contrast enhanced T1-weighted MRI. Advanced MRI techniques have been studied, but the diagnostic accuracy is not well known. Therefore, we performed a metaanalysis to assess the diagnostic accuracy of the currently available MRI techniques for treatment response.
The benefit for radiotherapy at specialised sarcoma centres: A systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association
Angela M. Hong a,b,c,⇑, Helen Lo c,d , Anna Lawless b,c , Deborah Zhou e,f , Susie Bae g , Marianne Phillips h , Fiona Maclean i,j , Jayesh Desai g , Jasmine Mar k , Smaro Lazarakis l , David Pryor m,n , Stephen R. Thompson o,p , Australia and New Zealand Sarcoma Association Guidelines Working Party
doi : 10.1016/j.radonc.2022.10.037
Volume 177, December 2022, Pages 158-162
Patients with sarcoma are best managed at specialised sarcoma centres as supported by published literature. Optimal management requires multidisciplinary team input to formulate the diagnosis and treatment sequencing taking into consideration multiple clinical and pathologic factors.
Late toxicity within a Phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES)
Supriya Chopra a,⇑, Nilesh Ranjan b , Mayuri Charnalia a , Sadhana Kannan c , Reena Engineer b , Tapas Dora d , Lavanya Gurram b , Prachi Mittal b , Amita Maheshwari f , Shylasree T.S. f , Shyam Shrivastava b , Sudeep Gupta
doi : 10.1016/j.radonc.2022.10.013
Volume 177, December 2022, Pages 16-20
This post-hoc analysis was performed to report the impact of Image guided intensity modulated radiotherapy (IG-IMRT) and three-dimensional conformal radiotherapy (3D-CRT) across organ system and grades of toxicity within PARCER trial (NCT 01279135).
Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial
Jørund Graadal Svestad a , Mojgan Heydari a , Stine Gyland Mikalsen a , Vidar Gordon Flote b , Fredrik Nordby b , Taran Paulsen Hellebust
doi : 10.1016/j.radonc.2022.10.017
Volume 177, December 2022, Pages 46-52
To prospectively investigate whether surface guided setup of right sided breast cancer patients can increase efficiency and accuracy compared to traditional skin marker/tattoo based setup.
Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial
Mette S. Thomsen a,⇑, Jan Alsner b , Hanne M. Nielsen c , Erik H. Jakobsen d , Mette H. Nielsen e , Mette Møller f , Anders N. Pedersen g , Esben Yates a , Martin Berg h , Ebbe Lorenzen i , Ingelise Jensen j , Mirjana Josipovic g , Jens Overgaard b , Birgitte V. Offersen b,c , on behalf of theDBCG RT Committee
doi : 10.1016/j.radonc.2022.09.024
Volume 177, December 2022, Pages 231-235
The relation between breast induration grade 2–3 at 3 years after radiation therapy and irradiated breast volume was investigated for patients in the Danish Breast Cancer Group (DBCG) Partial Breast Irradiation (PBI) trial.
Brachytherapy training survey among radiation oncology residents in Europe
Alina Emiliana Sturdza a,⇑, Marianne Stephanides b , Ina Jurgenliemk-Schulz c , Jesper Grau Eriksen d , Kim Benstead e , Peter Hoskin f , Stefanel Vlad g , Alexandre Escande h , Stefanie Corradini i , Johannes Knoth a , Henrike Westerveld j , Luca Tagliaferri k , Dina Najari-Jamali l , Katarzyna Konat-Baska m , Vesna Plesinac n , Li Tee Tan o , Remi Nout j , Vratislav Strnad p , Peter Niehoff q , Bradley R. Pieters r , Kari Tanderup d , Mitchell Kamrava
doi : 10.1016/j.radonc.2022.10.030
Volume 177, December 2022, Pages 172-178
We aim to investigate the current state of brachytherapy (BT) training among the radiation oncology trainees in Europe.
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer
Luca Visani a , Lorenzo Livi a,b , Ivica Ratosa c,d , Miha Orazem c,d , Domen Ribnikar d,e , Calogero Saieva f , Carlotta Becherini b , Viola Salvestrini a,b , Erika Scoccimarro a,b , Marianna Valzano a,b , Cecilia Cerbai a,b , Isacco Desideri a,b , Marco Bernini g , Lorenzo Orzalesi g , Jacopo Nori h , Simonetta Bianchi i , Andrea Morandi a , Icro Meattini
doi : 10.1016/j.radonc.2022.10.023
Volume 177, December 2022, Pages 40-45
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) currently represent the standard of care for the initial treatment of patients with metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer.
Ten-year results of hypofractionated whole breast radiotherapy and intraoperative electron boost in premenopausal women
Maria Cristina Leonardi a , Chiara Fausta Cormio a,b,1 , Samuele Frassoni c , Samantha Dicuonzo a,⇑, Cristiana Fodor a , Mattia Intra d , Maria Alessia Zerella a , Anna Morra a , Federica Cattani e , Stefania Comi e , Nicola Fusco b,f , Mattia Zaffaroni a , Viviana Galimberti d , Paolo Veronesi b,d , Silvia Dellapasqua g , Francesca De Lorenzi h , Giovanni Battista Ivaldi i , Vincenzo Bagnardi c , Roberto Orecchia j , Damaris Patricia Rojas a,2 , Barbara Alicja Jereczek-Fossa
doi : 10.1016/j.radonc.2022.10.025
Volume 177, December 2022, Pages 71-80
To evaluate outcome of intraoperative electron boost (IOERT) and hypofractionated whole breast irradiation (HWBI) for breast cancer (BC) in young women.
Dosimetric predictors of toxicity in a randomized study of short-course vs conventional radiotherapy for glioblastoma
Fan Yang a,1 , Deepak Dinakaran a,1 , Amr A. Heikal b , Shima Yaghoobpour Tari b , Sunita Ghosh c , John Amanie a , Albert Murtha a , Lindsay S. Rowe a , Wilson H. Roa a , Samir Patel
doi : 10.1016/j.radonc.2022.10.016
Volume 177, December 2022, Pages 152-157
There is no consensus on appropriate organ at risk (OAR) constraints for short-course radiotherapy for patients with glioblastoma. Using dosimetry and prospectively-collected toxicity data from a trial of short-course radiotherapy for glioblastoma, this study aims to empirically examine the OAR constraints, with particular attention to left hippocampus dosimetry and impact on neuro-cognitive decline.
Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study
Alan C. Hartford a,⇑, Gobind S. Gill a , Divya Ravi b , Tor D. Tosteson b,1 , Zhongze Li b , Gregory Russo a , Clifford J. Eskey a , Lesley A. Jarvis a , Nathan E. Simmons a , Linton T. Evans a , Benjamin B. Williams a , David J. Gladstone b , David W. Roberts b , Jay C. Buckey Jr.
doi : 10.1016/j.radonc.2022.10.024
Volume 177, December 2022, Pages 179-184
Increased oxygen levels may enhance the radiosensitivity of brain metastases treated with stereotactic radiosurgery (SRS). This project administered hyperbaric oxygen (HBO) prior to SRS to assess feasibility, safety, and response.
External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation
Pierfrancesco Franco a,⇑, Annamaria Porreca b , Giovanna Mantello c , Francesca Valvo d , Lucrezia Gasparini e , Najla Slim f , Stefania Manfrida g , Francesca De Felice h , Marianna A. Gerardi i , Stefano Vagge j , Marco Krengli a , Elisa Palazzari k , Mattia Falchetto Osti l , Alessandra Gonnelli m , Gianpiero Catalano n , Patrizia Pittoni o , Giovani B. Ivaldi p , Marco Lupattelli q , Maria Elena Rosetto r , Rita Marina Niespolo s , Alessandra Guido t , Oreste Durante u , Gabriella Macchia v , Fernando Munoz w , Badr El Khouzai x , Maria Rosaria Lucido y , Francesca Arcadipane z , Andrea Casadei Gardini aa , Rolando Maria D’Angelillo ab , Maria Antonietta Gambacorta g , Domenico Genovesi e,ac , Marta Di Nicola b , Luciana Caravatta
doi : 10.1016/j.radonc.2022.10.015
Volume 177, December 2022, Pages 9-15
A prognostic scoring system based on laboratory inflammation parameters, [Hemo-Eosinophils-Inflammation (HEI) index], including baseline hemoglobin level, the systemic inflammatory index and eosinophil count was recently proposed in patients with squamous cell carcinoma of the anus (ASCC).
Preliminary results of reduced myocardial blood flow in the subacute phase after radiation therapy for thoracic esophageal cancer: A quantitative analysis with stress dynamic myocardial computed tomography perfusion imaging
Akinori Takada a , Yasutaka Ichikawa a,⇑, Satoshi Nakamura a , Yutaka Toyomasu a , Tomoko Kawamura a , Yui Nanpei a , Takamitsu Mase a , Kazuki Omori a , Toshiro Mizuno b , Kakuya Kitagawa a , Masaki Ishida a , Noriko Ii c , Yoshihito Nomoto a , Hajime Sakuma
doi : 10.1016/j.radonc.2022.11.002
Volume 177, December 2022, Pages 191-196
Late adverse cardiac events after radiation therapy (RT) for thoracic malignancies are known, but the underlying mechanisms are poorly understood.
Development of a consensus-based delineation guideline for locally recurrent rectal cancer
Floor Piqeur a,b,c,1 , Britt J.P. Hupkens a,d,1 , Stefi Nordkamp e , Marnix G. Witte b , Philip Meijnen f , Heleen M. Ceha g , Maaike Berbee d , Margriet Dieters h , Sofia Heyman i , Alexander Valdman j , Martin P. Nilsson k , Joost Nederend l , Harm J.T. Rutten e,m , Jacobus W.A. Burger e , Corrie A.M. Marijnen b,c , Heike M.U. Peulen
doi : 10.1016/j.radonc.2022.11.008
Volume 177, December 2022, Pages 214-221
Neoadjuvant chemoradiotherapy (nCRT) is used in locally recurrent rectal cancer (LRRC) to increase chances of a radical surgical resection. Delineation in LRRC is hampered by complex disease presentation and limited clinical exposure. Within the PelvEx II trial, evaluating the benefit of chemotherapy preceding nCRT for LRRC, a delineation guideline was developed by an expert LRRC team.
Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein–Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma
Eric Yi-Liang Shen a,b , Tsung-Min Hung a , Din-Li Tsan a,c , Nai-Ming Cheng d , Chung-Jan Kang e , Shiang-Fu Huang e , Cheng-Lung Hsu f , Chien-Yu Lin a , Hung-Ming Wang f , Jason Chia-Hsun Hsieh f , Ann-Joy Cheng a,g , Kang-Hsing Fan h,⇑, Joseph Tung-Chieh ChangEric Yi-Liang Shen a,b , Tsung-Min Hung a , Din-Li Tsan a,c , Nai-Ming Cheng d , Chung-Jan Kang e , Shiang-Fu Huang e , Cheng-Lung Hsu f , Chien-Yu Lin a , Hung-Ming Wang f , Jason Chia-Hsun Hsieh f , Ann-Joy Cheng a,g , Kang-Hsing Fan h,⇑, Joseph Tung-Chieh Chang
doi : 10.1016/j.radonc.2022.05.004
Volume 177, December 2022, Pages 1-8
To determine the clinical impact of integrating Epstein–Barr virus (EBV) DNA and lymph node-to-primary tumor ratio (NTR) of positron emission tomography (PET) standardized uptake value (SUV) in predicting distant metastasis, such as distant metastasis-free survival (DMFS), in patients with nasopharyngeal carcinoma (NPC).
Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose–volume constraints with long-term endocrine outcomes
James C.H. Chow a,⇑, Jeffrey C.F. Lui a , Ka-Man Cheung a , Anthony H.P. Tam a , Martin H.C. Lam b , Tony Y.S. Yuen b , Francis K.H. Lee a , Alex K.C. Leung a , Kwok-Hung Au a , Wai-Tong Ng c,d , Anne W.M. Lee e , Chung-Kong Kwan b , Harry H.Y. Yiu a
doi : 10.1016/j.radonc.2022.10.034
Volume 177, December 2022, Pages 105-110
Post-radiation primary hypothyroidism is a common late complication in head and neck cancer (HNC) survivors. No radiation dose-volume constraint of the thyroid gland has been externally validated for predicting long-term thyroid function outcomes.
Lymph drainage and cervical fascia anatomy-oriented differential nodal CTV delineation at the supraclavicular region for esophageal cancer and nasopharyngeal cancer
Zuxian Zhong a,b , Dan Wang b,c , Yi Liu b,c , Shilong Shao d , Sihao Chen b,c , Shanshan He b,c , Ningjing Yang e , Churong Li b , Jing Ren e , Yue Zhao b , Qifeng Wang b , guotai Wang f , Chuntang Sun g , Shichuan Zhang
doi : 10.1016/j.radonc.2022.10.036
Volume 177, December 2022, Pages 113-120
To determine the differences in supraclavicular lymph node metastasis between esophageal cancer (EC) and nasopharyngeal cancer (NPC) and explore the feasibility of differential supraclavicular clinical target volume (CTV) contouring between these two diseases based on the involvement of different fascial spaces.
Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy
Amelia Barcellini a , Giulia Fontana b , Daria Maria Filippini c , Sara Ronchi a,⇑, Maria Bonora a , Barbara Vischioni a , Rossana Ingargiola a , Anna Maria Camarda a , Pierre Loap d , Nadia Facchinetti e , Lisa Licitra e,f,g , Guido Baroni b,h , Ester Orlandi
doi : 10.1016/j.radonc.2022.10.027
Volume 177, December 2022, Pages 143-151
In recent years, there is an emerging interest in the prognostic role of chemistry blood biomarkers in oncological patients but their role in adenoid cystic carcinomas (ACCs) is still unknown. This study aims to assess the prognostic significance of baseline neutrophil-to-lymphocyte ratio (NLR) and blood chemistry in a series of head and neck ACC patients treated with carbon ion radiotherapy (CIRT).
Dose response modelling of secretory cell loss in salivary glands using PSMA PET
Vineet Mohan a,b , Natascha M. Bruin a,b , Roel J.H.M. Steenbakkers c , Walter Noordzij d , Chris H.J. Terhaard e , Bart de Keizer f , Abrahim Al-Mamgani a , Jeroen B. van de Kamer a , Jan-Jakob Sonke a , Wouter V. Vogel
doi : 10.1016/j.radonc.2022.10.038
Volume 177, December 2022, Pages 164-171
Xerostomia remains a common side effect of radiotherapy (RT) for patients with head and neck (H&N) cancer despite advancements in treatment planning and delivery. Secretory salivary gland cells express the prostate-specific membrane antigen (PSMA), and show significant uptake on PET scans using 68Ga/18F-PSMA-ligands. We aimed to objectively quantify the dose–response of salivary glands to RT using PSMA PET.
Prognostic value of the cervical lymph node necrosis ratio in nasopharyngeal carcinoma
Ying Bin a,b,1 , Zhen Meng a,b,d,1 , Lu-Lu Huang a,b , Xue-Ying Hu a,b,c , Jun-Mei Song a,b , Yi-Ting Xie a,b,e , Min Kang a,b,c , Ren-Sheng Wang
doi : 10.1016/j.radonc.2022.11.007
Volume 177, December 2022, Pages 185-190
Whether cervical lymph node necrosis (CNN) is an independent adverse prognostic factor in nasopharyngeal carcinoma (NPC) has not been determined. In this study, the CNN ratio was graded quantitatively to explore the prognostic value in NPC.
Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study
Gaoyuan Wang 1 , Chenglong Huang 1 , Kaibin Yang, Rui Guo, Youyu Qiu, Wenfei Li, Yanping Mao, Linglong Tang 2 , Jun Ma
doi : 10.1016/j.radonc.2022.11.005
Volume 177, December 2022, Pages 205-213
Level Ib lymph nodes metastasis is rare in nasopharyngeal carcinoma (NPC). We aimed to evaluate the feasibility of sparing level Ib-irradiation in NPC patients with high-risk factors.
Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands
Jelle Evers a,b,⇑, Linda G.W. Kerkmeijer c,1 , Roderick C.N. van den Bergh d , Maurice J.C. van der Sangen e , Maarten C.C.M. Hulshof f,1 , Monique C.W.M. Bloemers g,2 , Sabine Siesling a,b , Mieke J. Aarts a , Katja K.H. Aben a,h , Henk Struikmans
doi : 10.1016/j.radonc.2022.10.028
Volume 177, December 2022, Pages 134-142
This population-based study describes nationwide trends and variation in the use of primary radiotherapy for non-metastatic prostate cancer in The Netherlands in 2008–2019.
Radiation prior to chimeric antigen receptor T-cell therapy is an optimizing bridging strategy in relapsed/refractory aggressive B-cell lymphoma
Qiuxia Yu 1 , Xiaoying Zhang 1 , Na Wang, Chunrui Li, Yicheng Zhang, Jianfeng Zhou, Gaoxiang Wang ⇑, Yang Cao
doi : 10.1016/j.radonc.2022.10.018
Volume 177, December 2022, Pages 53-60
We aimed to analyze the safety and efficacy of a radiation bridging regimen with or without chemotherapy compared with chemotherapy alone prior to CAR T-cell treatment for relapsed/refractory aggressive B-cell lymphoma (r/r ABL).
Effects of dose and dose-averaged linear energy transfer on pelvic insufficiency fractures after carbon-ion radiotherapy for uterine carcinoma
Yasumasa Mori a,b , Noriyuki Okonogi a,⇑, Shinnosuke Matsumoto c , Wataru Furuichi d , Mai Fukahori e , Yuhei Miyasaka b , Kazutoshi Murata a , Masaru Wakatsuki a , Reiko Imai a , Masashi Koto a , Shigeru Yamada a , Hitoshi Ishikawa a , Nobuyuki Kanematsu c , Hiroshi Tsuji
doi : 10.1016/j.radonc.2022.10.008
Volume 177, December 2022, Pages 33-39
The correlation between dose-averaged linear energy transfer (LETd) and its therapeutic or adverse effects, especially in carbon-ion radiotherapy (CIRT), remains controversial. This study aimed to investigate the effects of LETd and dose on pelvic insufficiency fractures after CIRT.
Comparison of atlas-based and deep learning methods for organs at risk delineation on head-and-neck CT images using an automated treatment planning system
Madalina Costea a,b , Alexandra Zlate c , Morgane Durand a , Thomas Baudier a,b , Vincent Grégoire a , David Sarrut a,b , Marie-Claude Biston
doi : 10.1016/j.radonc.2022.10.029
Volume 177, December 2022, Pages 61-70
To investigate the performance of head-and-neck (HN) organs-at-risk (OAR) automatic segmentation (AS) using four atlas-based (ABAS) and two deep learning (DL) solutions.
Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach
Sabine Visser a,⇑, Cássia O. Ribeiro a , Margriet Dieters a , Veronique E. Mul a , Anne G.H. Niezink a , Arjen van der Schaaf a , Antje-Christin Knopf a,b , Johannes A. Langendijk a , Erik W. Korevaar a , Stefan Both a , Christina T. Muijs a
doi : 10.1016/j.radonc.2022.11.001
Volume 177, December 2022, Pages 197-204
In the Netherlands, oesophageal cancer (EC) patients are selected for intensity modulated proton therapy (IMPT) using the expected normal tissue complication probability reduction (ΔNTCP) when treating with IMPT compared to volumetric modulated arc therapy (VMAT).
Patient-specific daily updated deep learning auto-segmentation for MRI-guided adaptive radiotherapy
Zhenjiang Li a,1 , Wei Zhang b,1 , Baosheng Li a , Jian Zhu a , Yinglin Peng c , Chengze Li b , Jennifer Zhu d , Qichao Zhou b,⇑, Yong Yin
doi : 10.1016/j.radonc.2022.11.004
Volume 177, December 2022, Pages 222-230
Deep Learning (DL) technique has shown great potential but still has limited success in online contouring for MR-guided adaptive radiotherapy (MRgART). This study proposed a patient-specific DL auto-segmentation (DLAS) strategy using the patient’s previous images and contours to update the model and improve segmentation accuracy and efficiency for MRgART.
Letter to the editor of radiotherapy and oncology regarding of the article “Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer� by Lalonde et al.
Kaixuan Yang Chuntang Sun ⇑ Rutie Yin
doi : 10.1016/j.radonc.2022.05.028
Volume 177, December 2022, Pages 240-241
Response to “Letter to the editor of radiotherapy and oncology regarding of the article “Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer� by Lalonde et al.�
Ronald Lalonde ⇑ Mohamed Abdelhakiem Andrew Keller M. Saiful Huq
doi : 10.1016/j.radonc.2022.05.032
Volume 177, December 2022, Page 242
Letter regarding “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials�
Zheng Li a,1 Yue Hu b,1 Qiang Li
doi : 10.1016/j.radonc.2022.09.018
Volume 177, December 2022, Pages 243-244
In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.�
Gustavo A. Viani a,b,⇑ Andre G. Gouveia b,c Fabio Y. Moraes
doi : 10.1016/j.radonc.2022.09.017
Volume 177, December 2022, Pages 245-246
Adjuvant chemotherapy and hypofractionated whole breast cancer radiotherapy: Is it time to rethink the sequencing?
Grazia Lazzari a,⇑ Luciana Rago a Angela P. Solazzo a Ilaria Benevento a Antonietta Montagna a Giovanni Castaldo a Giovanni Silvano
doi : 10.1016/j.radonc.2022.10.012
Volume 177, December 2022, Pages 247-248
Postoperative radiotherapy for ypN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery warrants further evaluation
Yongxing Bao Zhouguang Hui
doi : 10.1016/j.radonc.2022.10.032
Volume 177, December 2022, Pages 249-250
Response to Bao et al
Takefumi Komiya a,⇑ Shinkichi Takamori b Gregory Wilding
doi : 10.1016/j.radonc.2022.10.031
Volume 177, December 2022, Page 251
Letter to the editor of radiotherapy and oncology regarding the paper titled “Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.� by Huang et al.
Gargi S. Sarode Sachin C. Sarode ⇑ Rahul Anand
doi : 10.1016/j.radonc.2022.10.020
Volume 177, December 2022, Page 252
Response to Gargi S Sarode, Sachin C Sarode, and Rahul Anand’s Letter to the Editor of Radiotherapy and Oncology regarding the paper titled “Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.� by Huang et al.
Huageng Huang Jingjing Miao Chong Zhao ⇑ Lin Wang
doi : 10.1016/j.radonc.2022.10.022
Volume 177, December 2022, Page 253
Corrigendum to “Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study� [Radiother. Oncol. 172 (2022) 111–117]
James M. Price a,b , Catharine M. West b , Lynne M. Dixon c , Zsuzsanna Iyizoba-Ebozue d , Kate Garcez a , Lip Wai Lee a , Andrew McPartlin a , Gillian Williams e , Fin Slevin d , Andrew Sykes a , Robin J.D. Prestwich d , David J. Thomson
doi : 10.1016/j.radonc.2022.10.014
Volume 177, December 2022, Page 163
